Last reviewed · How we verify

NCT04936048: M4A

Music for Autism (M4A)

Completed NA Last updated 4 April 2025
What this trial tests

NA trial testing Music Therapy in Autism Spectrum Disorder in 68 participants. Completed in 31 December 2024.

Timeline
1 August 2021
Primary endpoint
17 December 2024
31 December 2024

Quick facts

Lead sponsorNORCE Norwegian Research Centre AS
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposetreatment
Enrollment68
Start date1 August 2021
Primary completion17 December 2024
Estimated completion31 December 2024
Sites2 locations across Austria, Norway

Drugs / interventions tested

Conditions studied

Sponsor

NORCE Norwegian Research Centre AS

Who can join

Adults 6 to 12, any sex, with Autism Spectrum Disorder or Autism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Music for Autism (M4A) trial evaluates the neurobehavioral outcomes of a music therapy (MT) intervention, compared to a matched play therapy (PT) intervention, on social communication skills, brain connectivity and structural brain changes. In a crossover randomised controlled trial (RCT), 80 children with autism across all levels of functioning, aged 6-12 years, undergo a baseline assessment, which includes measurements of social communication, participation, functional connectivity and brain structure. Participants are then randomly allocated to a sequence of interventions (MT-PT or PT-MT) and assessments are taken before and after each intervention period. Both interventions will target common goals and follow the same structure, while at the same time allowing for flexibility in the therapists' approach. It is hypothesized that 12 weeks of intervention through MT, compared to PT, will improve social communication skills, participation, and other relevant mental health outcomes in children with autism spectrum disorder (ASD), as well as regulate resting-state functional over and under-connectivity and increase grey and white matter volume in specified regions. The investigators also expect changes in functional brain connectivity to correlate with behavioural outcome measures, specifically with improved social communication skills.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Music therapy for autistic people.
    Geretsegger M, Fusar-Poli L, Elefant C, Mössler KA, et al · · 2022 · cited 43× · PMID 35532041 · DOI 10.1002/14651858.cd004381.pub4
  2. Music for autism: a protocol for an international randomized crossover trial on music therapy for children with autism.
    Ruiz M, Groessing A, Guran A, Koçan AU, et al · · 2023 · cited 2× · PMID 37886114 · DOI 10.3389/fpsyt.2023.1256771
  3. Design and implementation of a replication study: The Music for Autism (M4A) binational assessor-blinded randomised crossover trial
    Groessing A, Ruiz M, Guran A, Koçan A, et al · · 2023 · DOI 10.21203/rs.3.rs-2478719/v1

Verify or expand the search:

Other trials of Music Therapy

Trials testing the same drug.

Other recruiting trials for Autism Spectrum Disorder

Currently open trials in the same condition.

Other NORCE Norwegian Research Centre AS trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04936048.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing